The discovery of leptin, the product of the ob gene, has led to major developments in understanding the regulation of energy balance. It is now recognised that leptin is produced in several organs additional to white adipose tissue, including brown fat, the placenta and fetal tissues (such as heart and bonea acartilage). The hormone has multiple functions Ð in inhibiting food intake, in the stimulationa amaintenance of energy expenditure, as a signal to the reproductive system and as a`metabolic' hormone in¯uencing a range of processes (for example, insulin secretion, lipolysis, sugar transport). The production of leptin by white fat is subject to a number of regulatory in¯uences, including insulin and glucocorticoids (which are stimulatory), and fasting and b b-adrenoceptor agonists (which are inhibitory). A key role in the regulation of leptin production by white fat is envisaged for the sympathetic system, operating through b b3-adrenoceptors. The leptin receptor gene is widely expressed, with the several splice variants exhibiting different patterns of expression. The long form variant (Ob-Rb) is expressed particularly in the hypothalamus, although it is being increasingly identi®ed in other tissues. Leptin exerts its central effects through several neuroendocrine systems, including neuropeptide Y, glucagon-like peptide-1, melanocortins, corticotrophin releasing hormone (CRH) and cocaine-and amphetamine-regulated transcript (CART). In essence, the leptin system now appears highly complex, the hormone being involved in a range of physiological processes in a manner far transcending the initial lipostatic concept. This complexity may reduce the potential of the leptin system as a target for anti-obesity therapy.
Introduction
The identi®cation in 1994 of the ob (obese) gene and its protein product, leptinÐa 16 000 Mr cytokine-like hormone (also known as OB protein)Ðby Friedman and colleagues 1 has had considerable impact on our understanding of energy balance and on obesity research. It has, in particular, provided a molecular basis to the lipostatic theory of energy balance regulation, 2 and has led to the description of a previously unknown endocrine system. It has also provided a new target both for the development of anti-obesity drugs and in the search for genes which may be linked to the predisposition to obesity.
The initial concept following the discovery of leptin was that of a factor derived essentially from adipose tissue which acts centrally to inhibit food intake, by signalling the extent of the adipose tissue mass. 1 Such a view implies that leptin is secreted into the circulation and enters the brain, binding to speci®c receptors. It was also thought that there is a negative feedback loop to adipose tissue from the physiological function elicited by the hormone. This perspective has evolved rapidly over the past three and a half years, in terms of: (i) where leptin is produced, (ii) the location of the receptors, and (iii) the functions that are in¯uenced by the hormone.
Background
The genetically obese (obaob) mouse was ®rst noted in the late 1940's following a spontaneous mutation in a colony of mice maintained at the Jackson Laboratories, USA. Over the succeeding half century obaob mice have been extensively studied; indeed by virtue of their extreme obesity of early onset, obaob mice have been widely used as models in the investigation of the regulation of energy balance. Despite the number and range of nutritional, physiological and biochemical studies to which these mice have been subject, the fundamental defect has remained elusive. It was only through the application of positional cloning that the mutant gene was identi®ed and a new endocrine system revealed. 1 The obaob mouse is one of several single gene mutants which are characterised by an obese phenotype. The mutant genes responsible for obesity in the diabetic (dbadb) mouse, the yellow agouti mouse (agouti), the fat (fatafat) mouse, the tubby (tubatub) mouse and the Zucker (faafa) rat have each been identi®ed (see Ref. 3) . The dbadb mouse and the faafa rat are of particular signi®cance in relation to leptin, since the mutation that these animals carry relates to the receptor for the hormone.
4 ± 6 Thus, obese mutants occur which involve both the hormone and its receptor, the phenotype and associated abnormalities being generally similar in each case. Human parallels are now recognised with the description of obese subjects with mutations in leptin or the leptin receptor. 7 ± 9 One of the tangential bene®ts that has¯owed from the identi®cation of the ob gene and the other mutant genes causing obesity in rodents is that the large gulf that had existed between those working on humans and those undertaking basic studies on experimental animals has narrowed considerably. Indeed, there is now a widespread recognition of the importance of animal studies in obesity research, particularly in the identi®cation of`novel' genes and gene products.
Functions of leptin
Leptin was initially considered to be a satiety factor and there is no doubt that it has a substantial effect on food intake, 10 ± 12 particularly in obaob mice which are naive with respect to the hormone. Our own data, for example, found a 75 ± 80% reduction in food intake in obaob mice following the administration of recombinant murine leptin. 13 There was also a decrease in the food intake of similarly treated lean mice, but this was rather smaller (20% reduction) than in the mutant animals. 13 Although leptin is still widely described as a satiety factor, a range of other effects of the hormone have been documented. Leptin has a stimulatory effect on energy expenditure, 10 ± 12 or a primary role in maintaining expenditure, 14 thus interacting with both components of the energy balance relationship. One of the key developments in leptin biology has been the recognition that the hormone plays an important role as a signal to the reproductive system. obaob mice are infertile and administration of the recombinant hormone restores their fertility. 15 Furthermore, injection of leptin brings forward the age of sexual maturation in normal weanling mice and the timing of the ®rst litter. 16, 17 Morphological and hormonal changes, consistent with a major role for leptin in the reproductive system, have also been described, including the stimulation of the release of luteinizing hormone and of follicle-stimulating hormone from tissue explants (see Ref. 18) . Leptin also appears increasingly as a general metabolic' hormone, in that a rapidly expanding range of processes with which it interacts are being documented. These include the inhibition of insulin secretion from the b-cells of the pancreas, 19, 20 the stimulation of glucose utilisation (particularly uptake by skeletal muscle), 21 the stimulation of lipolysis in adipocytes 22 and the stimulation of sugar transport across the small intestine. 23 Other roles attributed to leptin include it being considered as a stimulatory factor in haematopoiesis. 24 Where is leptin produced?
White adipose tissue continues to be regarded as the key site of leptin production, but it is now evident that the hormone is also produced in other tissues. Brown adipose tissue (the other form of adipose tissue) synthesises the hormone, although the level of expression of the ob gene is lower in brown fat than in white fat, at least in rats and mice. 25 ± 27 The physiological role of leptin produced by brown fat is not clear, but one possibility is that it simply adds to the pool of circulating hormone as a re¯ection of the total amount of adipose tissue (white and brown). If this is the case, then the contribution of brown adipose tissue would be small relative to that of white fat. 28 The signi®cance of brown fat as a site of leptin synthesis is made especially problematic by the fact that the tissue is not present in all mammals and nor is it necessarily evident throughout life in those species in which it does occur (see Ref. 29 ).
An intriguing dimension to leptin biology has come with the recognition that the placenta expresses the ob gene and is a site of production of the hormone. 30 ± 32 Placental synthesis suggests that leptin may either be a novel growth factor or act as a signal of energyanutrient status between the mother and the fetus. The placenta also expresses the leptin receptor gene, implying that the organ is a target for the action of leptin as well as being a source of the hormone. 18, 30 In situ hybridisation and immunohistochemical studies on pregnant mice have demonstrated leptin synthesis in several regions of the fetus, including the heart, boneacartilage and cells of the hair follicle. 18 These tissues do not appear to synthesise leptin in the adult, suggesting either a growth factor function in the fetus or re¯ecting the postulated role in haematopoiesis.
In the past decade, white adipose tissue has become increasingly recognised as a highly heterogeneous organ, with the distribution of body fat being important in relation to the pathology of obesity. Although all white fat depots seem to express the ob gene, there are considerable differences between sites in the relative level of ob mRNA. 33, 34 In adult rodents, ob mRNA level is much higher in the gonadal and perirenal depots than in subcutaneous tissue. 33 In contrast, in suckling rats during the ®rst 1 ± 2 weeks after birth, the subcutaneous fat is the main site of ob gene expression. 35 If relative levels of ob mRNA re¯ect leptin production, it would seem that there are substantial differences between depots in the extent to which they contribute to the total circulating pool of the hormone. Furthermore, the rodent data implies that there are substantial developmental shifts in the importance of different adipose tissue sites to leptin production. In suckling animals, the subcutaneous fat is of greatest importance, while in the mature animal the internal depots are more signi®cant.
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There are also species variations. In adult humans the subcutaneous adipose tissue has higher levels of ob mRNA and is likely, therefore, to be more important in leptin production, than the omental tissue. 36, 37 The production of a hormone at varying levels from a number of different sites raises challenges in terms of co-ordination, particularly given the evidence that leptin is secreted in a pulsatile manner. 38, 39 Regulation of leptin production in white adipose tissue
The level of ob mRNA in white fat and the circulating leptin concentration are increased markedly in obesity, as noted in both human studies and in different types of obese animal. 40 ± 47 In humans, there is a strong direct correlation between body mass index (BMI) and circulating leptin. 46, 47 Thus, in general, the greater the amount of adipose tissue, the higher the level of the hormone; indeed adiposity is the primary determinant of leptin concentration. Acute regulation of leptin synthesis is, however, superimposed on the intrinsic production associated with the size of the adipose tissue mass.
A number of factors which acutely in¯uence the production of leptin have been identi®ed from in vivo studies on laboratory rodents and from cell culture studies (Figure 1 ). Physiological in¯uences include fasting, exercise and exposure to cold, each of which result in a fall in ob gene expression and a corresponding reduction in the circulating level of leptin (see references 33, 45, and 48 ± 51). Following fasting, refeeding leads to a rapid restoration of gene expression and of circulating leptin. 33, 45, 48, 50 The production of leptin is therefore subject to nutritional control in a way which is consistent with a central signalling role for the hormone in the regulation of energy balance.
Glucocorticoids and insulin stimulate ob gene expression and leptin production. 50 ± 54 In contrast, thiazolidinediones, noradrenaline and isoprenaline each inhibit gene expression and reduce circulating leptin levels. 48,49,55 ± 57 We have recently found that adrenaline also rapidly induces a marked fall in circulating leptin (Mostyn, Rayner and Trayhurn, unpublished results). The effect of catecholamines occurs primarily though the b3-adrenoceptor, since selective b3-agonists have a powerful inhibitory effect on ob gene expression and leptin production. 57 ± 59 This has led to the view that the sympathetic nervous system (SNS) provides a negative feedback loop to white adipose tissue, regulating leptin synthesis by inhibiting ob gene transcription through b3-adrenoceptors. 48Y 49Y 57 There is also evidence of a regulatory role for catecholamines in leptin production of humans, infusion of isoprenaline inducing an acute suppression of plasma leptin. 60 A pivotal role for the sympathetic system in the regulation of leptin production?
Whilst there are a number of factors which acutely in¯uence leptin production, an important issue is whether physiologically any particular factor plays a predominant roleÐ and whether normally, some factors have little physiological signi®cance. There is a parallel with the regulation of lipolysis in white fat, which can involve an array of hormones, including glucagon, catecholamines and adrenocorticotropin (see reference 61). It has, however, long been considered that in vivo the SNS is the key regulator of lipolysis. 61 Apart from any direct effects of noradrenaline secreted by the SNS within white fat, there is also the possibility of an indirect interaction via the sympathetic innervation of the adrenals with the release of adrenaline into the circulation.
Until recently, direct changes in sympathetic activity in white adipose tissue in response to physiological stimuli, which result in increased lipolysis, had not been demonstrated. However, a study measuring noradrenaline turnover has now shown that sympathetic activity in white fat is increased on cold exposure, 62 paralleling the increase in sympathetic stimulation that occurs to brown adipose tissue and the heart in the cold (see references 29,48 and 63) . It has also been demonstrated that fasting, on the other hand, selectively increases sympathetic activity in white fat, 64 in contrast to brown adipose tissue and the heart where there is a marked decrease. 48, 63 From these observations it is pertinent to ask whether the reduction in circulating leptin, during fasting, is the consequence of an inhibitory effect on ob gene transcription resulting from increased SNS activity to white fat. 28, 48 Some direct evidence in support of such a notion comes from a study showing that administration of the b-adrenoceptor antagonist, propranolol, led to an attenuation in the fasting-induced reduction in circulating leptin. 48 The rate limiting enzyme in the synthesis of noradrenaline is tyrosine hydroxylase and this can be strongly inhibited by a-methyl-p-tyrosine. Administration of a-methyl-p-tyrosine to mice at levels Figure 1 The main factor involved in the regulation of leptin production in white adipose tissue. IL-1 interleukin-1; SNS sympathetic nervous system; TNFa tumour necrosis factor-a. A dominant role may be played by the sympathetic system.
employed in, and with a protocol similar to, studies on noradrenaline turnover, induces a rapid increase (up to eight-fold within 6 ± 10 h) in the circulating level of leptin. 48, 65 Thus blockade of noradrenaline production leads to marked hyperleptinaemia, and this appears to be due to increased synthesis since the level of ob mRNA in epididymal white fat is increased by treatment with a-methyl-p-tyrosine. 65 Direct stimulation of b3-adrenoceptors by administration of a b3-agonist attenuates the effects of the blockade of noradrenaline synthesis on leptin production, as would be predicted. 65 Overall, these data are consistent with the concept that the SNS plays a dominant role in the regulation of leptin production in white adipose tissue through modulating the transcription of the ob gene.
With respect to humans, a recent note has reported the case of a patient with phaeochromocytoma. 66 One month after adrenalectomy to remove the tumour, there was a major fall in circulating noradrenaline and adrenaline (and in the urinary excretion of both catecholamines), while serum leptin increased signi®-cantly.
Leptin receptors
As a result of alternative splicing, the leptin receptor occurs as a series of splice variants, the Ob-Ra, ObRb, Ob-Rc, Ob-Rd, Ob-Re forms being initially identi®ed. 6 One or more splice variant is expressed in most, if not all, tissues, 67 with the Ob-Ra form, in particular, being found widely. The extensive distribution of leptin receptor gene expression is indicative of the hormone having a range of targets and is consistent with the growing evidence of a multiplicity of functions. The Ob-Ra splice variant is thought to be a leptin transporter, while the Ob-Re form appears to be a soluble binding protein.
The variant which has received most attention is Ob-Rb, which is a long form containing an intracellular signalling domain. 6 The Ob-Rb variant was ®rst thought to have a highly restricted distribution, being principally located in regions of the brain. 68, 69 However, there are reports of the identi®cation of Ob-Rb in an increasing number of tissues, including the kidneys, adrenal medulla, b-cells of the pancreas, the placenta, ovaries and adipose tissue. 19, 67, 70 In situ hybridisation studies on the mouse brain have demonstrated that the leptin receptor gene is strongly expressed in the choroid plexus, the leptomeninges and the hypothalamus, with the long form variant being expressed particularly in regions of the hypothalamus, such as the arcuate nucleus. 68, 69 mRNA studies on leptin receptor gene expression, in the hypothalamus, have now been supported by immunohistochemical studies on the localisation of receptor protein. 71 The hypothalamus is clearly a key target for leptin, which accords with the role for this region of the brain in the regulation of energy balance.
Neuroendocrine interactions
There is strong evidence, both from functional studies and from the co-localisation of leptin and preproneuropeptide Y gene expression, that hypothalamic neuropeptide Y (NPY) is an important neuroendocrine target for leptin, and this is consistent with the fact that NPY both stimulates food intake and decreases energy expenditure. 72, 73 The NPY system is not, however, the only central target for leptin, NPY knockout mice responding to the hormone. 74 Additional neuroendocrine systems with which leptin interacts include glucagon-like peptide-1, 75 corticotrophin releasing hormone 76, 77 and the pro-opiomelanocrotin system, there being both functional and co-localisation studies which indicate an interaction with these speci®c neuropeptides. 72 Cocaine-and amphetamineregulated transcript (CART), the most recently identi®ed neuropeptide associated with the control of food intake, is also a neuroendocrine target for leptin. 79 Apart from NPY, all the neuropeptide systems with which leptin has been clearly shown to interact, inhibit food intake and each is upregulated by the peripherally-derived hormone (Figure 2 ).
There may also be an interaction with the stimulatory peptides galanin and melanin-concentrating hormone. 71, 80 Protein co-localisation occurs additionally between the leptin receptor and several other neuropeptides, including vasopressin and oxytocin. 71 Colocalisation in the same neurones does not in itself mean that there is necessarily a speci®c interaction, but the possibility is certainly raised. Overall, it is evident that leptin is a peripheral signal which interacts with a multiplicity of neuroendocrine targets (Figure 2) . Figure 2 Neuroendocrine interactions of leptin. CART cocaine-and amphetamine-regulated transcript; CRH corticotrophin releasing hormone; GHRH growth hormone releasing hormone; GLP-1 glucagon-like peptide-1; MCH melanin concentrating hormone; NPY neuropeptide Y; POMC pro-opiomelanocortin.
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Human leptin and leptin receptor mutations
Several polymorphisms in the leptin and leptin receptor genes have been described, but there is, as yet, no clear association with obesity. However, three reports have now identi®ed mutations in the coding region of these genes, together with severe obesity. 7 ± 9 In the ®rst report, obesity was described in two young children with a mutation in codon 133 of the mRNA for leptin. 7 In the others, which involved older subjects, mutations in the leptin or leptin receptor genes were associated with hypogonadism, as well as with marked obesity. 8, 9 Thus there are human equivalents of the obaob and the dbadb mouse; indeed one of the reports on human subjects has identi®ed a mutation in the same codon (105) as that causing a premature stop codon in the obaob mouse. 8 The signi®cance of these ®ndings is not the presence of the mutations per se, but the demonstration that the leptin system is as important physiologically for the regulation of body fat and energy balance in man as it is in rodents. The studies also indicate that leptin is a critical signal for the maturation of the reproductive system in humans, again paralleling the situation in experimental animals.
Diagnostic potential of leptin
Several commercial radioimmunoassays (RIAs) and ELISAs for leptin are now available, although measurement of the hormone is currently still very much in the research phase. It is, however, likely that the analysis of circulating leptin may become a diagnostic tool in the near future. It is possible to envisage screening of the obese to identify those individuals with low leptin levels for their BMI, implying leptin de®ciency (and potentially a target group for leptin therapy) or those with very high leptin levels, who might be genuinely leptin resistant. In addition, screening for leptin might be valuable in the assessment of reproductive disorders such as amennorhea and delayed puberty, as well as in a variety of metabolic conditions given the growing evidence of leptin as a`metabolic' hormone.
Coda
In the short period since its discovery, our view of leptin has changed dramaticallyÐfrom a relatively simple lipostatic paradigm to that of an endocrine system of considerable complexity. This complexity is exhibited in terms of where the hormone is produced, the range of receptor variants and target tissues, the number of neuroendocrine systems with which there is an interaction and, most importantly of all, the diverse physiological functions in which leptin is involved. The complexity, particularly in terms of function, means that the leptin system has become much more problematic as a target for the development of novel therapeutic agents in the treatment of obesity.
Note added in Proof
Since this manuscript was submitted the stomach has been identi®ed as a further site of leptin production, 81 and two major new functions for the hormone are suggested ± as a signal to the immune system 82 and as an angiogenic factor. 83 Angiogenesis may be the primary reason why the placenta produces leptin and shows high expression of the leptin receptor gene. 30 
